|
|
||||||||
1 Department of Emergency Medicine and 2 Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Brigham and Women's Hospital, Boston 02115; 4 Department of Pathology, Boston University School of Medicine, Boston, Massachusetts 02118; and 3 Department of Biomedical Sciences, Baylor College of Dentistry, Dallas, Texas 75246
Hyperbaric oxygen (HBO) is being studied as a therapeutic intervention for ischemia/reperfusion (I/R) injury. We have developed an in vitro endothelial cell model of I/R injury to study the impact of HBO on the expression of intercellular adhesion molecule-1 (ICAM-1) and polymorphonuclear leukocyte (PMN) adhesion. Human umbilical vein endothelial cell (HUVEC) and bovine aortic endothelial cell (BAEC) induction of ICAM-1 required simultaneous exposure to both hypoxia and hypoglycemia as determined by confocal laser scanning microscopy, ELISA, and Western blot. HBO treatment reduced the expression of ICAM-1 to control levels. Adhesion of PMNs to BAECs was increased following hypoxia/hypoglycemia exposure (3.4-fold, P < 0.01) and was reduced to control levels with exposure to HBO (P = 0.67). Exposure of HUVECs and BAECs to HBO induced the synthesis of endothelial cell nitric oxide synthase (eNOS). The NOS inhibitor nitro-L-arginine methyl ester attenuated HBO-mediated inhibition of ICAM-1 expression. Our findings suggest that the beneficial effects of HBO in treating I/R injury may be mediated in part by inhibition of ICAM-1 expression through the induction of eNOS.
cell adhesion molecules; ischemia; reperfusion injury; hyperoxia; neutrophils
This article has been cited by other articles:
![]() |
S. Efrati, S. Berman, G. B. Aharon, Y. Siman-Tov, Z. Averbukh, and J. Weissgarten Application of normobaric hyperoxia therapy for amelioration of haemorrhagic shock-induced acute renal failure Nephrol. Dial. Transplant., July 1, 2008; 23(7): 2213 - 2222. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hink, S. R. Thom, U. Simonsen, I. Rubin, and E. Jansen Vascular reactivity and endothelial NOS activity in rat thoracic aorta during and after hyperbaric oxygen exposure Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1988 - H1998. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. P. Cabigas, J. Su, W. Hutchins, Y. Shi, R. B. Schaefer, R. F. Recinos, V. Nilakantan, E. Kindwall, J. A. Niezgoda, and J. E. Baker Hyperoxic and hyperbaric-induced cardioprotection: Role of nitric oxide synthase 3 Cardiovasc Res, October 1, 2006; 72(1): 143 - 151. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Lewis, H. Goldztein, and D. Deschler Use of hyperbaric oxygen to enhance auricular composite graft survival in the rabbit model. Arch Facial Plast Surg, September 1, 2006; 8(5): 310 - 313. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Alex, G. Laden, A. R.J. Cale, S. Bennett, K. Flowers, L. Madden, E. Gardiner, P. T. McCollum, and S. C. Griffin Pretreatment with hyperbaric oxygen and its effect on neuropsychometric dysfunction and systemic inflammatory response after cardiopulmonary bypass: A prospective randomized double-blind trial J. Thorac. Cardiovasc. Surg., December 1, 2005; 130(6): 1623 - 1630. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sanada, H. Asanuma, T. Minamino, K. Node, S. Takashima, H. Okuda, Y. Shinozaki, A. Ogai, M. Fujita, A. Hirata, et al. Optimal Windows of Statin Use for Immediate Infarct Limitation: 5'-Nucleotidase as Another Downstream Molecule of Phosphatidylinositol 3-Kinase Circulation, October 12, 2004; 110(15): 2143 - 2149. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-K. Han, J.-S. Kim, B.-H. Park, J.-R. Kim, B.-Y. Hwang, H.-Y. Lee, E.-K. Song, and W.-H. Yoo NF-{kappa}B-dependent lymphocyte hyperadhesiveness to synovial fibroblasts by hypoxia and reoxygenation: potential role in rheumatoid arthritis J. Leukoc. Biol., April 1, 2003; 73(4): 525 - 529. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Remahl, R Ansjon, F Lind, and E Waldenlind Hyperbaric Oxygen Treatment of Active Cluster Headache: A Double-Blind Placebo-Controlled Cross-Over Study Cephalalgia, November 1, 2002; 22(9): 730 - 739. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |